Literature DB >> 19158554

Excimer laser phototherapeutic keratectomy for keratoconus nodules.

Ahmed F Elsahn1, Christopher J Rapuano, Victor A Antunes, Yasmine F Abdalla, Elisabeth J Cohen.   

Abstract

PURPOSE: To report the outcomes of contact lens-intolerant patients with keratoconus (KCN) with subepithelial nodules treated with excimer laser phototherapeutic keratectomy (PTK).
METHODS: The charts of all contact lens-intolerant patients with KCN who underwent excimer laser PTK for subepithelial nodules were identified using a computer database and were retrospectively reviewed. Preoperative and postoperative visual acuity and method of correction, surgical treatment, epithelial healing, complications, and KCN nodule recurrence were all analyzed.
RESULTS: Fifteen eyes of 15 patients with a minimum follow-up of 3 months were reviewed. Mean follow-up time was 23.1 months (SD +/- 42.5 months, range 3-143 months). In 9 eyes, the epithelial defect healed by postoperative day 3 and all eyes healed by postoperative day 6. There was no infection or corneal melting in any of the eyes. After PTK, 11 patients were refit successfully with rigid gas-permeable contact lenses and 4 wore glasses. Three patients had a recurrence of the KCN nodule at 3, 8, and 23 months postoperatively. One of them had a repeat PTK 23 months after the initial surgery, improving to 20/40 with contact lenses at 55 months postoperatively. Another patient decided to have a penetrating keratoplasty, and the third patient is considering repeat PTK or penetrating keratoplasty.
CONCLUSION: PTK effectively removed KCN nodules without recurrences in most patients and can be a successful modality to improve contact lens tolerance and delay or avoid more invasive surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19158554     DOI: 10.1097/ICO.0b013e31818526b8

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Bevel toric multicurve rigid gas-permeable lens for keratoconus.

Authors:  Ryoji Yanai; Kiichi Ueda; Koh-Hei Sonoda
Journal:  Jpn J Ophthalmol       Date:  2012-12-07       Impact factor: 2.447

2.  Comparison of the Effect of Epithelial Removal by Transepithelial Phototherapeutic Keratectomy or Manual Debridement on Cross-linking Procedures for Progressive Keratoconus.

Authors:  Ronald N Gaster; J Ben Margines; David N Gaster; Xiaohui Li; Yaron S Rabinowitz
Journal:  J Refract Surg       Date:  2016-10-01       Impact factor: 3.573

3.  Transepithelial Phototherapeutic Keratectomy Using a 213-nm Solid-State Laser System Followed by Corneal Collagen Cross-Linking with Riboflavin and UVA Irradiation.

Authors:  George D Kymionis; Michael A Grentzelos; Alexandra E Karavitaki; George A Kounis; Georgios A Kontadakis; Sonia Yoo; Ioannis G Pallikaris
Journal:  J Ophthalmol       Date:  2010-11-02       Impact factor: 1.909

4.  Role of optical coherence tomography on corneal surface laser ablation.

Authors:  Bruna V Ventura; Haroldo V Moraes; Newton Kara-Junior; Marcony R Santhiago
Journal:  J Ophthalmol       Date:  2012-09-05       Impact factor: 1.909

5.  Anterior stromal puncture for treatment of contact lens-intolerant keratoconus patients.

Authors:  Su Yeon Kang; Young Kee Park; Jong-Suk Song; Hyo Myung Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-13       Impact factor: 3.117

Review 6.  Phototherapeutic keratectomy.

Authors:  Varsha M Rathi; Sharadini P Vyas; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

Review 7.  Nonsurgical Procedures for Keratoconus Management.

Authors:  L Rico-Del-Viejo; M Garcia-Montero; J L Hernández-Verdejo; S García-Lázaro; F J Gómez-Sanz; A Lorente-Velázquez
Journal:  J Ophthalmol       Date:  2017-12-21       Impact factor: 1.909

8.  [Stage-appropriate treatment of keratoconus].

Authors:  B Seitz; L Daas; L Hamon; K Xanthopoulou; S Goebels; C Spira-Eppig; S Razafimino; N Szentmáry; A Langenbucher; E Flockerzi
Journal:  Ophthalmologe       Date:  2021-06-28       Impact factor: 1.174

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.